David H Henry

Summary

Publications

  1. ncbi request reprint Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors
    David Henry
    Joan Karnell Cancer Center, Pennsylvania Hospital, 230 W Washington Square, Philadelphia, PA, 19106, USA
    Support Care Cancer 22:679-87. 2014
  2. doi request reprint Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron
    David H Henry
    Department of Medicine, Pennsylvania Hospital, University of Pennsylvania, Philadelphia, Pennsylvania 19106, USA
    Am J Hematol 87:308-10. 2012
  3. doi request reprint Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma
    David H Henry
    Joan Karnell Cancer Center, Philadelphia, PA 19106, USA
    J Clin Oncol 29:1125-32. 2011
  4. doi request reprint Parenteral iron therapy in cancer-associated anemia
    David H Henry
    Joan Karnell Cancer Center at Pennsylvania Hospital, Philadelphia, PA 19106, USA
    Hematology Am Soc Hematol Educ Program 2010:351-6. 2010
  5. ncbi request reprint Guidelines and recommendations for the management of anaemia in patients with lymphoid malignancies
    David H Henry
    Joan Karnell Cancer Center, Pennsylvania Hospital, Philadelphia, Pennsylvania 19106, USA
    Drugs 67:175-94. 2007
  6. ncbi request reprint Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy
    David H Henry
    Joan Karnell Cancer Center, Pennsylvania Hospital, 230 West Washington Square, Philadelphia, PA 19106, USA
    Oncologist 12:231-42. 2007
  7. ncbi request reprint Epoetin alfa. Clinical evolution of a pleiotropic cytokine
    David H Henry
    Pennsylvania Hospital, Joan Karnell Cancer Center, Philadelphia, PA 19106, USA
    Arch Intern Med 164:262-76. 2004
  8. ncbi request reprint Natural history of anemia associated with interferon/ribavirin therapy for patients with HIV/HCV coinfection
    David H Henry
    Joan Karnell Cancer Center, Pennsylvania Hospital, Philadelphia, PA 19106, USA
    AIDS Res Hum Retroviruses 23:1-9. 2007
  9. ncbi request reprint Epoetin alfa for the treatment of cancer- and chemotherapy-related anaemia: product review and update
    David H Henry
    Joan Karnell Cancer Center, Pennsylvania Hospital, 230 West Washington Square, 2nd Floor, Philadelphia, PA 19106, USA
    Expert Opin Pharmacother 6:295-310. 2005
  10. ncbi request reprint Randomized, open-label comparison of epoetin alfa extended dosing (80 000 U Q2W) vs weekly dosing (40 000 U QW) in patients with chemotherapy-induced anemia
    David H Henry
    Joan Karnell Cancer Center, Pennsylvania Hospital, Philadelphia, PA, USA
    Curr Med Res Opin 22:1403-13. 2006

Detail Information

Publications19

  1. ncbi request reprint Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors
    David Henry
    Joan Karnell Cancer Center, Pennsylvania Hospital, 230 W Washington Square, Philadelphia, PA, 19106, USA
    Support Care Cancer 22:679-87. 2014
    ..This ad hoc analysis reports outcomes in the subgroup of 1,597 patients with solid tumors, excluding patients with multiple myeloma...
  2. doi request reprint Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron
    David H Henry
    Department of Medicine, Pennsylvania Hospital, University of Pennsylvania, Philadelphia, Pennsylvania 19106, USA
    Am J Hematol 87:308-10. 2012
    ..Our study suggests that ESA associated VTE in CIA patients may be, in part, related to the thrombocytosis of ESA induced iron restricted erythropoiesis and may be countered by IV iron...
  3. doi request reprint Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma
    David H Henry
    Joan Karnell Cancer Center, Philadelphia, PA 19106, USA
    J Clin Oncol 29:1125-32. 2011
    ....
  4. doi request reprint Parenteral iron therapy in cancer-associated anemia
    David H Henry
    Joan Karnell Cancer Center at Pennsylvania Hospital, Philadelphia, PA 19106, USA
    Hematology Am Soc Hematol Educ Program 2010:351-6. 2010
    ....
  5. ncbi request reprint Guidelines and recommendations for the management of anaemia in patients with lymphoid malignancies
    David H Henry
    Joan Karnell Cancer Center, Pennsylvania Hospital, Philadelphia, Pennsylvania 19106, USA
    Drugs 67:175-94. 2007
    ..Clearly, an update on the definition, identification and optimal management of anaemia in patients with lymphoid malignancies is warranted...
  6. ncbi request reprint Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy
    David H Henry
    Joan Karnell Cancer Center, Pennsylvania Hospital, 230 West Washington Square, Philadelphia, PA 19106, USA
    Oncologist 12:231-42. 2007
    ..To evaluate the safety and efficacy of intravenous (IV) sodium ferric gluconate complex (FG), oral ferrous sulfate, or no iron to increase hemoglobin (Hb) in anemic cancer patients receiving chemotherapy and epoetin alfa...
  7. ncbi request reprint Epoetin alfa. Clinical evolution of a pleiotropic cytokine
    David H Henry
    Pennsylvania Hospital, Joan Karnell Cancer Center, Philadelphia, PA 19106, USA
    Arch Intern Med 164:262-76. 2004
    ..The therapeutic potential of epoetin alfa appears yet to be fully realized...
  8. ncbi request reprint Natural history of anemia associated with interferon/ribavirin therapy for patients with HIV/HCV coinfection
    David H Henry
    Joan Karnell Cancer Center, Pennsylvania Hospital, Philadelphia, PA 19106, USA
    AIDS Res Hum Retroviruses 23:1-9. 2007
    ..sEPO and reticulocyte increases were blunted in response to anemia; Hb levels did not return to baseline values and anemia was a frequent reason for discontinuing the study...
  9. ncbi request reprint Epoetin alfa for the treatment of cancer- and chemotherapy-related anaemia: product review and update
    David H Henry
    Joan Karnell Cancer Center, Pennsylvania Hospital, 230 West Washington Square, 2nd Floor, Philadelphia, PA 19106, USA
    Expert Opin Pharmacother 6:295-310. 2005
    ..Areas of recent and ongoing investigation with epoetin alfa are also covered in this review...
  10. ncbi request reprint Randomized, open-label comparison of epoetin alfa extended dosing (80 000 U Q2W) vs weekly dosing (40 000 U QW) in patients with chemotherapy-induced anemia
    David H Henry
    Joan Karnell Cancer Center, Pennsylvania Hospital, Philadelphia, PA, USA
    Curr Med Res Opin 22:1403-13. 2006
    ..This randomized, open-label, multicenter study compared the efficacy and safety of epoetin alfa (EPO) 80 000 U every 2 weeks (Q2W) to the FDA-approved regimen of 40 000 U weekly (QW) in patients with chemotherapy-induced anemia...
  11. ncbi request reprint The role of intravenous iron in cancer-related anemia
    David H Henry
    Department of Medicine, Pennsylvania Hospital, Philadelphia, Pennsylvania 19106, USA
    Oncology (Williston Park) 20:21-4. 2006
    ..v. iron supplementation in improving the hematopoietic responses in these patients...
  12. doi request reprint Hematologic outcomes and blood utilization in cancer patients with chemotherapy-induced anemia (CIA) pre- and post-national coverage determination (NCD): results from a multicenter chart review
    David H Henry
    Joan Karnell Cancer Center, Pennsylvania Hospital, Philadelphia, PA 19106, USA
    Support Care Cancer 20:2089-96. 2012
    ..The primary objective of this study was to compare transfusion rates in patients with CIA with lung, breast, or colorectal cancer before and after the NCD...
  13. ncbi request reprint The evolving role of epoetin alfa in cancer therapy
    David H Henry
    Joan Karnell Cancer Center, Pennsylvania Hospital, Philadelphia, Pennsylvania 19106, USA
    Oncologist 9:97-107. 2004
    ..Thus, the role of epoetin alfa is likely to expand in the cancer setting in the coming years...
  14. ncbi request reprint Epoetin alfa for treatment of anemia in HIV-infected patients: past, present, and future
    David H Henry
    Department of Oncology, Hematology, Pennsylvania Hospital, Philadelphia, PA 19106, USA
    J Acquir Immune Defic Syndr 37:1221-7. 2004
    ..Current and future research will further clarify the role of epoetin alfa in the clinical management of the HIV-infected population...
  15. ncbi request reprint Optimizing the treatment of anemia in cancer patients. The role of a new erythropoietic agent
    David H Henry
    Joan Karnell Cancer Center, Pennsylvania Hospital, Philadelphia 19106, USA
    Oncology (Williston Park) 16:9-12. 2002
    ..The articles in this supplement describe the basic scientific research and clinical development of darbepoetin alfa--another safe, effective, and approved treatment for chemotherapy-induced anemia...
  16. ncbi request reprint Blood management in total joint arthroplasty
    Hari R Bezwada
    Balderston Orthopaedics, Pennsylvania Hospital, 800 Spruce St, Philadelphia, PA 19107, USA
    Am J Orthop (Belle Mead NJ) 35:458-64. 2006
    ..This article reviews these techniques as well as the consequences of perioperative anemia. Problems associated with blood transfusions are also outlined...
  17. doi request reprint Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S
    David H Henry
    Joan Karnell Cancer Center, Pennsylvania Hospital, 230 W Washington Square, Philadelphia, PA, 19106, USA
    Support Care Cancer 16:791-801. 2008
    ..To examine the prevalence of chemotherapy-or radiotherapy-associated side effects and related treatment burden, and correlates of fatigue and missed work days among cancer patients...
  18. ncbi request reprint Preoperative use of recombinant human erythropoietin before total joint arthroplasty
    Hari P Bezwada
    Pennsylvania Hospital, Philadelphia, 19107, USA
    J Bone Joint Surg Am 85:1795-800. 2003
    ..The purpose of this study was to evaluate the efficacy of erythropoietin in combination with, and compared with, preoperative autologous donation for reducing allogeneic blood requirements for total joint arthroplasty...
  19. doi request reprint Phase 1/2 trial of BMS-275291 in patients with human immunodeficiency virus-related Kaposi sarcoma: a multicenter trial of the AIDS Malignancy Consortium
    Brett T Brinker
    Division of Hematology Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University and the Robert H Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA
    Cancer 112:1083-8. 2008
    ....